Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?

Blepharospasm Dystonia Epidemiology Sensory trick Vascular risk factors

Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 08 05 2023
revised: 06 08 2023
accepted: 06 09 2023
pubmed: 18 9 2023
medline: 18 9 2023
entrez: 17 9 2023
Statut: ppublish

Résumé

Although acquired dystonia may develop following ischaemic/haemorrhagic stroke, the relationship between cerebrovascular disease and idiopathic dystonia has been poorly investigated. This cross sectional study aimed at evaluating the impact of cerebrovascular risk factors on the clinical expression of idiopathic adult onset dystonia (IAOD), with reference to dystonia localization and dystonia-associated features. Data were obtained from the Italian Dystonia Registry. Patients with IAOD were stratified into two groups according to the presence of diabetes mellitus and/or arterial hypertension and/or dyslipidemia and/or heart disease. The two groups were compared for demographic features, dystonia phenotype, and dystonia-associated features (sensory trick, tremor, eye symptoms in blepharospasm, and neck pain in cervical dystonia). A total of 1108 patients participated into the study. Patients who reported one cerebrovascular factor or more (n = 555) had higher age and longer disease duration than patients who did not. On multivariable logistic regression analysis, blepharospasm was the only localization, and sensory trick was the only dystonia-associated feature that was significantly associated with cerebrovascular risk factors. Linear regression analysis showed that the strength of the association between cerebrovascular factors and blepharospasm/sensory trick increased with increasing the number of cerebrovascular factors per patient. Results of the present study showed that cerebrovascular risk factors may be associated with specific features of IAOD that is development of blepharospasm and sensory trick. Further studies are needed to better understand the meaning and the mechanisms underlying this association.

Sections du résumé

BACKGROUND BACKGROUND
Although acquired dystonia may develop following ischaemic/haemorrhagic stroke, the relationship between cerebrovascular disease and idiopathic dystonia has been poorly investigated. This cross sectional study aimed at evaluating the impact of cerebrovascular risk factors on the clinical expression of idiopathic adult onset dystonia (IAOD), with reference to dystonia localization and dystonia-associated features.
METHODS METHODS
Data were obtained from the Italian Dystonia Registry. Patients with IAOD were stratified into two groups according to the presence of diabetes mellitus and/or arterial hypertension and/or dyslipidemia and/or heart disease. The two groups were compared for demographic features, dystonia phenotype, and dystonia-associated features (sensory trick, tremor, eye symptoms in blepharospasm, and neck pain in cervical dystonia).
RESULTS RESULTS
A total of 1108 patients participated into the study. Patients who reported one cerebrovascular factor or more (n = 555) had higher age and longer disease duration than patients who did not. On multivariable logistic regression analysis, blepharospasm was the only localization, and sensory trick was the only dystonia-associated feature that was significantly associated with cerebrovascular risk factors. Linear regression analysis showed that the strength of the association between cerebrovascular factors and blepharospasm/sensory trick increased with increasing the number of cerebrovascular factors per patient.
CONCLUSIONS CONCLUSIONS
Results of the present study showed that cerebrovascular risk factors may be associated with specific features of IAOD that is development of blepharospasm and sensory trick. Further studies are needed to better understand the meaning and the mechanisms underlying this association.

Identifiants

pubmed: 37717501
pii: S1353-8020(23)00930-6
doi: 10.1016/j.parkreldis.2023.105851
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105851

Investigateurs

Claudio Zaccone (C)
Denise Cerne (D)
Giovanni Idone (G)
Gina Ferrazzano (G)
Sara Rinaldo (S)
Kais Humaidan (K)
Grazia Devigili (G)
Luigi Polidori (L)
Sonia Mazzucchi (S)
Marina Ramella (M)
Claudia Ledda (C)
Martina Petracca (M)
Valentina Oppo (V)
Elena Contaldi (E)
Marinella Turla (M)
Angelo Fabio Gigante (AF)
Francesca Valentino (F)
Daniela Cassano (D)
Nicola Modugno (N)
Nicola Tambasco (N)
Marco Aguggia (M)
Marcello Romano (M)
Lucio Marinelli (L)

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None

Auteurs

Marcello Mario Mascia (MM)

Neurology Unit, University Hospital of Cagliari, Cagliari, Italy. Electronic address: marcello.mas@tiscali.it.

Daniele Belvisi (D)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; IRCCS Neuromed, Pozzilli, Italy.

Marcello Esposito (M)

Clinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy.

Roberta Pellicciari (R)

Department of Translational Biomedicine and Neuroscience, University of Bari, Bari, Italy.

Assunta Trinchillo (A)

Department of Neurosciences, Reproductive Sciences and Odontostomatology, "Federico II" University, Naples, Italy.

Carmen Terranova (C)

Department of clinical and Experimental Medicine, University of Messina, Messina, Italy.

Salvatore Bertino (S)

Department of clinical and Experimental Medicine, University of Messina, Messina, Italy.

Laura Avanzino (L)

Department of Experimental Medicine, Section of Human Physiology, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Francesca Di Biasio (F)

IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Francesco Bono (F)

Center for Botulinum Toxin Therapy, Neurologic Unit, A.O.U. Mater domini, Catanzaro, Italy.

Vincenzo Laterza (V)

Center for Botulinum Toxin Therapy, Neurologic Unit, A.O.U. Mater domini, Catanzaro, Italy.

Christian Lettieri (C)

Neurology Unit, University Hospital S.Maria della Misericordia, Udine, Italy.

Roberto Eleopra (R)

Neurology Unit, University Hospital S.Maria della Misericordia, Udine, Italy; Neurology Unit 1, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Giovanni Fabbrini (G)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; IRCCS Neuromed, Pozzilli, Italy.

Pierangelo Barbero (P)

Neurology Unit, Mauriziano Umberto I Hospital, Turin, Italy.

Laura Bertolasi (L)

Neurologic Unit, University Hospital, Verona, Italy.

Maria Concetta Altavista (MC)

Neurology Unit, San Filippo Neri Hospital ASL Roma 1, Rome, Italy.

Roberto Erro (R)

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana" University of Salerno, Salerno, Italy.

Roberto Ceravolo (R)

Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Anna Castagna (A)

IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Maurizio Zibetti (M)

Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Turin, Italy.

Anna Rita Bentivoglio (AR)

Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy; Institute of Neurology, Università Cattolica del Sacro Cuore, Rome, Italy.

Giovanni Cossu (G)

Neurology Service and Stroke Unit, Department of Neuroscience, AO Brotzu, Cagliari, Italy.

Luca Magistrelli (L)

Movement Disorders Centre, Neurology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; PhD programme in clinical and Experimental Medicine and Medical Humanities, University of Insubria, Varese, Italy.

Cesa Scaglione (C)

IRCCS Institute of Neurological Sciences, Bologna, Italy.

Alberto Albanese (A)

Department of Neurology, IRCCS, Istituto Clinico Humanitas, Rozzano, Milan, Italy.

Maria Sofia Cotelli (MS)

Neurology Unit (ASST Valcamonica) Esine, Brescia, Italy.

Salvatore Misceo (S)

Neurology Unit, San Paolo Hospital, Bari, Italy.

Antonio Pisani (A)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; IRCCS Mondino Foundation, Pavia, Italy.

Tommaso Schirinzi (T)

Department of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy.

Luca Maderna (L)

Department of Neurology and Laboratory of Neuroscience, IRCCS, Istituto Auxologico Italiano, Milan, Italy.

Giovanna Squintani (G)

Neurology Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Alfredo Berardelli (A)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; IRCCS Neuromed, Pozzilli, Italy.

Giovanni Defazio (G)

Department of Translational Biomedicine and Neuroscience, University of Bari, Bari, Italy.

Classifications MeSH